We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease

Product News   May 24, 2018

 
Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease

Credit: Cambridge Research Biochemicals

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

ERS Genomics and GenScript Biotech Corporation Sign CRISPR/Cas9 License Agreement

Product News

ERS Genomics Limited and GenScript Biotech Corporation have announced a non-exclusive license agreement granting GenScript access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

READ MORE

FUJIFILM Irvine Scientific Celebrates 50 Years of Excellence in Cell Culture

Product News

FUJIFILM Irvine Scientific, Inc. is celebrating its 50th year of providing cell culture media products and services.

READ MORE

UK Diagnostic Company Collaborates With UK COV-AD Trial

Product News

Oxford Immunotec has announced that its T-SPOT®.COVID test will be used for T cell testing in the COV-AD (COVID infection in patients with Antibody Deficiency) study in collaboration with the University of Birmingham.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE